Analysis of graft survival in a trial of stem cell transplant in ALS

Abstract

OBJECTIVE The first US Food and Drug Administration-approved clinical trial to treat amyotrophic lateral sclerosis (ALS) with neural stem cell-based therapy is in progress. The goal of the current study was to identify and assess the survival of human spinal cord-derived neural stem cells (HSSCs) transplanted into the spinal cord in patients with ALS… (More)
DOI: 10.1002/acn3.134

4 Figures and Tables

Topics

  • Blog articles referencing this paper

  • Presentations referencing similar topics